Below are links to press releases and ongoing information on clinical trials for DAIDS-networks and affiliated partners. If you would like to submit a press release or publication for the site, click here.  

Partners PrEP and CDC TDF2 show promising results for PrEP's effectiveness in preventing HIV transmission. Partners PrEP studied serodiscordant couples in Kenya and Uganda, and reported 62%-73% fewer HIV infections in participants randomized to PrEP. In the CDC TDF2 study, PrEP  reportedly reduced HIV infection by 63%.

Click here to learn more about iPrEx and network responses to the study, and to check out other PrEP trials that are ongoing or in development.